Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Precision-guided treatment in high-risk pediatric cancers

    Recent research showed that precision medicine can identify new treatment strategies for patients with childhood cancers. However, it is unclear which patients will benefit most from precision-guided treatment...

    Loretta M. S. Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, Marie Wong in Nature Medicine (2024)

  2. Article

    Open Access

    Atypical splicing variants in PKD1 explain most undiagnosed typical familial ADPKD

    Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of kidney failure and is primarily associated with PKD1 or PKD2. Approximately 10% of patients remain undiagnosed after stan...

    Yvonne Hort, Patricia Sullivan, Laura Wedd, Lindsay Fowles in npj Genomic Medicine (2023)

  3. Article

    Open Access

    Introme accurately predicts the impact of coding and noncoding variants on gene splicing, with clinical applications

    Predicting the impact of coding and noncoding variants on splicing is challenging, particularly in non-canonical splice sites, leading to missed diagnoses in patients. Existing splice prediction tools are comp...

    Patricia J. Sullivan, Velimir Gayevskiy, Ryan L. Davis, Marie Wong in Genome Biology (2023)

  4. Article

    Open Access

    A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer

    Molecular profiling of the tumour immune microenvironment (TIME) has enabled the rational choice of immunotherapies in some adult cancers. In contrast, the TIME of paediatric cancers is relatively unexplored. ...

    Chelsea Mayoh, Andrew J. Gifford, Rachael Terry, Loretta M. S. Lau in Genome Medicine (2023)

  5. Article

    Open Access

    Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL

    Teresa Sadras, Fatimah B. Jalud, Hansen J. Kosasih, Christopher R. Horne in Leukemia (2023)

  6. Article

    Open Access

    Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes

    Diffuse midline gliomas (DMG) harbouring H3K27M mutation are paediatric tumours with a dismal outcome. Recently, a new subtype of midline gliomas has been described with similar features to DMG, including loss...

    Pamela Ajuyah, Chelsea Mayoh, Loretta M. S. Lau, Paulette Barahona in Scientific Reports (2023)

  7. Article

    Open Access

    Diagnostic classification of childhood cancer using multiscale transcriptomics

    The causes of pediatric cancers’ distinctiveness compared to adult-onset tumors of the same type are not completely clear and not fully explained by their genomes. In this study, we used an optimized multileve...

    Federico Comitani, Joshua O. Nash, Sarah Cohen-Gogo, Astra I. Chang in Nature Medicine (2023)

  8. Article

    Open Access

    Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions

    ABL-class fusions including NUP214-ABL1 and EBF1-PDGFRB occur in high risk acute lymphoblastic leukaemia (ALL) with gene expression patterns similar to BCR-ABL-positive ALL. Our aim was to evaluate new DNA-based ...

    Nicola C. Venn, Libby Huang, Lenka Hovorková, Walter Muskovic in British Journal of Cancer (2022)

  9. Article

    Open Access

    Glutamine addiction promotes glucose oxidation in triple-negative breast cancer

    Glutamine is a conditionally essential nutrient for many cancer cells, but it remains unclear how consuming glutamine in excess of growth requirements confers greater fitness to glutamine-addicted cancers. By ...

    Lake-Ee Quek, Michelle van Geldermalsen, Yi Fang Guan, Kanu Wahi, Chelsea Mayoh in Oncogene (2022)

  10. Article

    Open Access

    Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma

    Minimal residual disease (MRD) measurement is a cornerstone of contemporary acute lymphoblastic leukaemia (ALL) treatment. The presence of immunoglobulin (Ig) and T cell receptor (TCR) gene recombinations in l...

    Vinod Vijay Subhash, Libby Huang, Alvin Kamili, Marie Wong in British Journal of Cancer (2022)

  11. Article

    Open Access

    ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing data

    Whole genome sequencing (WGS) has the potential to outperform clinical microarrays for the detection of structural variants (SV) including copy number variants (CNVs), but has been challenged by high false pos...

    Andre E. Minoche, Ben Lundie, Greg B. Peters, Thomas Ohnesorg in Genome Medicine (2021)

  12. Article

    Open Access

    Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor

    The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy. Treatment with chemoradiation approaches has not signif...

    Sumanth Nagabushan, Loretta M. S. Lau, Paulette Barahona in npj Precision Oncology (2021)

  13. No Access

    Article

    Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

    The Zero Childhood Cancer Program is a precision medicine program to benefit children with poor-outcome, rare, relapsed or refractory cancer. Using tumor and germline whole genome sequencing (WGS) and RNA sequ...

    Marie Wong, Chelsea Mayoh, Loretta M. S. Lau, Dong-Anh Khuong-Quang in Nature Medicine (2020)

  14. Article

    Open Access

    Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

    Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understandi...

    Laura A. Baker, Holly Holliday, Daniel Roden, Christoph Krisp in Breast Cancer Research (2020)

  15. Article

    Open Access

    The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly

    Population health research is increasingly focused on the genetic determinants of healthy ageing, but there is no public resource of whole genome sequences and phenotype data from healthy elderly individuals. ...

    Mark Pinese, Paul Lacaze, Emma M. Rath, Andrew Stone in Nature Communications (2020)

  16. Article

    Open Access

    Development and validation of a targeted gene sequencing panel for application to disparate cancers

    Next generation sequencing has revolutionised genomic studies of cancer, having facilitated the development of precision oncology treatments based on a tumour’s molecular profile. We aimed to develop a targete...

    Mark J. McCabe, Marie-Emilie A. Gauthier, Chia-Ling Chan in Scientific Reports (2019)

  17. No Access

    Article

    Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity

    Resisting and tolerating microbes are alternative strategies to survive infection, but little is known about the evolutionary mechanisms controlling this balance. Here genomic analyses of anatomically modern h...

    Nathan W. Zammit, Owen M. Siggs, Paul E. Gray, Keisuke Horikawa in Nature Immunology (2019)

  18. No Access

    Article

    Increased Diagnostic Yield of Spastic Paraplegia with or Without Cerebellar Ataxia Through Whole-Genome Sequencing

    Inherited disorders of spasticity or ataxia exist on a spectrum with overlap** causative genes and phenotypes. We investigated the use of whole-genome sequencing (WGS) to detect a genetic cause when consider...

    Aryun Kim, Kishore R. Kumar, Ryan L. Davis, Amali C. Mallawaarachchi in The Cerebellum (2019)

  19. Article

    Open Access

    Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer

    Our understanding of genomic heterogeneity in lung cancer is largely based on the analysis of early-stage surgical specimens. Here we used endoscopic sampling of paired primary and intrathoracic metastatic tum...

    Tracy L. Leong, Velimir Gayevskiy, Daniel P. Steinfort, Marc R. De Massy in Oncogene (2019)

  20. No Access

    Article

    High Degree of Genetic Heterogeneity for Hereditary Cerebellar Ataxias in Australia

    Genetic testing strategies such as next-generation sequencing (NGS) panels and whole genome sequencing (WGS) can be applied to the hereditary cerebellar ataxias (HCAs), but their exact role in the diagnostic p...

    Ce Kang, Christina Liang, Kate E. Ahmad, Yufan Gu, Sue-Faye Siow in The Cerebellum (2019)

previous disabled Page of 2